Supplementary Table S3 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry

Supplementary Table S3 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry

<p>Differentially methylated genes in HNC patients by race</p>

Enregistré dans:

Détails bibliographiques
Auteur principal:	Nadia Mezghani (15055724) (author)
Autres auteurs:	Alexandria Yao (15055727) (author), Daria Vasilyeva (15055730) (author), Nicole Kaplan (15055733) (author), Austin Shackelford (15055736) (author), Angela Yoon (15055739) (author), Elizabeth Phillipone (15055742) (author), Sunil Dubey (15055745) (author), Gary K. Schwartz (15054959) (author), Alison M. Taylor (15055748) (author), Fatemeh Momen-Heravi (10160853) (author)
Publié:	2025
Sujets:	Cancer Therapeutic Research and Development Clinical Research and Trials Head, Neck & Oral Cancers Precision Medicine Translational Research
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Supplementary Table S1 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry
par: Nadia Mezghani (15055724)
Publié: (2025)

Supplementary Table S4 from Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry
par: Nadia Mezghani (15055724)
Publié: (2025)

Tables 2 from Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111–24111)
par: Simon P. Beyaert (17141915)
Publié: (2025)

Tables 3 from Tumor Microenvironment Modifications Induced by Afatinib in Squamous Cell Carcinoma of the Head and Neck: A Window-of-Opportunity Study (EORTC-90111–24111)
par: Simon P. Beyaert (17141915)
Publié: (2025)

Supplementary Figure from Mutated HRAS Activates YAP1–AXL Signaling to Drive Metastasis of Head and Neck Cancer
par: Sankar Jagadeeshan (15112900)
Publié: (2025)

Supplementary Figure 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
par: Michelle L. Mierzwa (14963463)
Publié: (2025)

Supplementary Figures 1 from Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors
par: Luana Guimaraes Sousa (16534377)
Publié: (2025)

Supplementary Appendix S1 from DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
par: Bouchra Tawk (15389486)
Publié: (2025)

Supplementary Figure S1 from Negative Predictive Value of Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA for HPV-driven Oropharyngeal Cancer Surveillance
par: Glenn J. Hanna (15036909)
Publié: (2025)

Supplementary Data 1 from Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma
par: Chen Chen (16799528)
Publié: (2025)

Supplementary Data 3 from Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma
par: Chen Chen (16799528)
Publié: (2025)

Supplementary Data 4 from Targeting KDM2A Enhances T-cell Infiltration in NSD1-Deficient Head and Neck Squamous Cell Carcinoma
par: Chen Chen (16799528)
Publié: (2025)

Figure S1 from Multicenter Randomized Double-Blind Phase III Trial of Donafenib in Progressive Radioactive Iodine-Refractory Differentiated Thyroid Cancer
par: Yansong Lin (16374208)
Publié: (2025)

Supplementary Figure S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
par: Abdullah A. Osman (15056323)
Publié: (2025)

Supplementary Table S1 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
par: Abdullah A. Osman (15056323)
Publié: (2025)

Supplementary Table S2 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
par: Abdullah A. Osman (15056323)
Publié: (2025)

Supplementary Table S3 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
par: Abdullah A. Osman (15056323)
Publié: (2025)

Supplementary Table S4 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
par: Abdullah A. Osman (15056323)
Publié: (2025)

Supplementary Table S5 from Dysregulation and Epigenetic Reprogramming of NRF2 Signaling Axis Promote Acquisition of Cisplatin Resistance and Metastasis in Head and Neck Squamous Cell Carcinoma
par: Abdullah A. Osman (15056323)
Publié: (2025)

Supplementary Table S1 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
par: Aleksandar Obradovic (7549517)
Publié: (2025)

Supplementary Table S2 from Immunostimulatory Cancer-Associated Fibroblast Subpopulations Can Predict Immunotherapy Response in Head and Neck Cancer
par: Aleksandar Obradovic (7549517)
Publié: (2025)

Supplementary Figure S1 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
par: Sarita Paudel (15047430)
Publié: (2025)

Supplementary Figure S2 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
par: Sarita Paudel (15047430)
Publié: (2025)

Supplementary Figure S3 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
par: Sarita Paudel (15047430)
Publié: (2025)

Supplementary Figure S4 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
par: Sarita Paudel (15047430)
Publié: (2025)

Supplementary Figure S5 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
par: Sarita Paudel (15047430)
Publié: (2025)

Supplementary Figure S6 from Serologic Profiling Using an Epstein-Barr Virus Mammalian Expression Library Identifies EBNA1 IgA as a Prediagnostic Marker for Nasopharyngeal Carcinoma
par: Sarita Paudel (15047430)
Publié: (2025)

Supplementary Table S1 from Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities
par: Yibin Dai (16374331)
Publié: (2025)

Supplementary Table S2 from Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities
par: Yibin Dai (16374331)
Publié: (2025)

Supplementary File 1 from Cetuximab Responses in Patients with HNSCC Correlate to Clonal Expansion Feature of Peripheral and Tumor-Infiltrating T Cells with Top T-Cell Receptor Clonotypes
par: Huaibin Ge (15047462)
Publié: (2025)

The STRIDOR mnemonic as a learning aid for post-operative ward care of head and neck cancer patients: a pilot randomized educational intervention trial
par: Ahmed Bassiouni (723398)
Publié: (2025)

Supplementary Table S1 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
par: Jonathan M.J. Derry (16648337)
Publié: (2025)

Supplementary Table S2 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
par: Jonathan M.J. Derry (16648337)
Publié: (2025)

Supplementary Table S3 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
par: Jonathan M.J. Derry (16648337)
Publié: (2025)

Supplementary Table S4 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
par: Jonathan M.J. Derry (16648337)
Publié: (2025)

Supplementary Table S5 from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
par: Jonathan M.J. Derry (16648337)
Publié: (2025)

Supplementary Table S6A from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
par: Jonathan M.J. Derry (16648337)
Publié: (2025)

Supplementary Table S6B from Trackable Intratumor Microdosing and Spatial Profiling Provide Early Insights into Activity of Investigational Agents in the Intact Tumor Microenvironment
par: Jonathan M.J. Derry (16648337)
Publié: (2025)

Supplementary Table from CircIPO7 Promotes Nasopharyngeal Carcinoma Metastasis and Cisplatin Chemoresistance by Facilitating YBX1 Nuclear Localization
par: Xiaohong Hong (22681698)
Publié: (2025)

Supplementary file 3: Supplementary Tables. from circFNDC3B Accelerates Vasculature Formation and Metastasis in Oral Squamous Cell Carcinoma
par: Xiang Li (15386727)
Publié: (2025)

Cannot write session to /tmp/vufind_sessions/sess_5btesurj3iga7ppq851tja9hrd